Atlas Trials

Study of Remdesivir in Participants Below 18 Years Old With COVID-19

Clinical trial NCT04431453 · COMPLETED

Trial details

NCT number
NCT04431453
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-07-21
Primary completion
2023-02-10
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.